Amgen's FGFR2b-targeting cancer candidate boosts overall survival in phase 3 - Fierce Biotech

Amgen's FGFR2b-targeting cancer candidate boosts overall survival in phase 3  Fierce Biotech

Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor ...

Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-Line Gastric Cancer  Business Wire

Amgen and Zai Lab’s trial of gastric cancer therapy meets primary endpoint - Yahoo Finance

Amgen and Zai Lab’s trial of gastric cancer therapy meets primary endpoint  Yahoo Finance

Amgen, Zai Lab succeed in gastric cancer study (AMGN:NASDAQ) - Seeking Alpha

Amgen, Zai Lab succeed in gastric cancer study (AMGN:NASDAQ)  Seeking Alpha

Zai Lab price target raised to $75 from $73 at Leerink - TipRanks

Zai Lab price target raised to $75 from $73 at Leerink  TipRanks

ZLAB Stock: Leerink Partners Raises Price Target for Zai Lab to $75 | ZLAB Stock News - GuruFocus

ZLAB Stock: Leerink Partners Raises Price Target for Zai Lab to $75 | ZLAB Stock News  GuruFocus

Trump zai gana da shugabannin nahiyar Afirka - DW

Trump zai gana da shugabannin nahiyar Afirka  DW

Revenues Not Telling The Story For Zai Lab Limited (NASDAQ:ZLAB) After Shares Rise 33% - simplywa...

Revenues Not Telling The Story For Zai Lab Limited (NASDAQ:ZLAB) After Shares Rise 33%  simplywall.st

Zai Lab (ZLAB) chief legal officer sells $212k in shares - Investing.com

Zai Lab (ZLAB) chief legal officer sells $212k in shares  Investing.com

BBC Content Job: Zai Bennett Drops Out Of Charlotte Moore Race - Deadline

BBC Content Job: Zai Bennett Drops Out Of Charlotte Moore Race  Deadline

Zai Lab’s Promising Phase 3 Trial Results and Future Potential Justify Buy Rating - TipRanks

Zai Lab’s Promising Phase 3 Trial Results and Future Potential Justify Buy Rating  TipRanks

Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor ...

Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-Line Gastric Cancer  Yahoo

Amgen (AMGN) and Zai Lab Report Positive Trial Results for Gastric Cancer Treatment - GuruFocus

Amgen (AMGN) and Zai Lab Report Positive Trial Results for Gastric Cancer Treatment  GuruFocus

Zai Lab Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Update...

Zai Lab Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Updates  Business Wire

Lula zai gana da Kirchner ta Argentina da ke daurin talala - DW

Lula zai gana da Kirchner ta Argentina da ke daurin talala  DW

Zai Lab stock price target raised to $75 from $73 at Leerink Partners - Investing.com Australia

Zai Lab stock price target raised to $75 from $73 at Leerink Partners  Investing.com Australia

Zai Lab’s Promising Growth: Successful Trial and Expanding Pipeline Drive Buy Rating - TipRanks

Zai Lab’s Promising Growth: Successful Trial and Expanding Pipeline Drive Buy Rating  TipRanks

Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor ...

Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-Line Gastric Cancer | ZLAB Stock News  GuruFocus

Zai Lab announces FORTITUDE-101 clinical trial meets primary endpoint - TipRanks

Zai Lab announces FORTITUDE-101 clinical trial meets primary endpoint  TipRanks

Zai Lab Limited Announces Key Management Changes - TipRanks

Zai Lab Limited Announces Key Management Changes  TipRanks

China’s First Police Corgi Has 400,000 Followers and a Nose for Trouble - The New York Times

China’s First Police Corgi Has 400,000 Followers and a Nose for Trouble  The New York Times

Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis - Yahoo ...

Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis  Yahoo Finance

Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Tr...

Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025  Business Wire

Zai Lab stock price target raised to $75 from $73 at Leerink Partners - Investing.com India

Zai Lab stock price target raised to $75 from $73 at Leerink Partners  Investing.com India

Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conju...

Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conjugate, for Treatment of Extensive-Stage Small Cell Lung Cancer  Business Wire

Zai Lab Ltd (ZLAB) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Ya...

Zai Lab Ltd (ZLAB) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...  Yahoo Finance

Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AAC...

Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting  Business Wire

Khrystyna Zai performs at event celebrating the Kurt & Marilyn Wallach Holocaust and Jewish Studi...

Khrystyna Zai performs at event celebrating the Kurt & Marilyn Wallach Holocaust and Jewish Studies Building  Florida Atlantic University

Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Main...

Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore  Business Wire

Zai Lab's Bemarituzumab Meets Primary Endpoint in Phase 3 Trial for Gastric Cancer - MarketScreener

Zai Lab's Bemarituzumab Meets Primary Endpoint in Phase 3 Trial for Gastric Cancer  MarketScreener

Ropes & Gray Advises Zai Lab on $200 Million Secondary Offering - Ropes & Gray LLP

Ropes & Gray Advises Zai Lab on $200 Million Secondary Offering  Ropes & Gray LLP

Zai Lab Limited Is Well Positioned For Long-Term Growth - Seeking Alpha

Zai Lab Limited Is Well Positioned For Long-Term Growth  Seeking Alpha

Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates - Business Wire

Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates  Business Wire

Zai Lab ADR Earns Relative Strength Rating Upgrade - Investor's Business Daily

Zai Lab ADR Earns Relative Strength Rating Upgrade  Investor's Business Daily

Zai Lab Announces Third Quarter 2024 Financial Results and Recent Corporate Updates - Business Wire

Zai Lab Announces Third Quarter 2024 Financial Results and Recent Corporate Updates  Business Wire

Zai Lab Limited (ZLAB): Among the Best Breakout Stocks to Buy According to Analysts - Yahoo Finance

Zai Lab Limited (ZLAB): Among the Best Breakout Stocks to Buy According to Analysts  Yahoo Finance

Meet Zai . - Bold Journey Magazine

Meet Zai .  Bold Journey Magazine

Zai Lab Presents Data Highlighting Potential of Internally Developed, Next-Generation Oncology Th...

Zai Lab Presents Data Highlighting Potential of Internally Developed, Next-Generation Oncology Therapies at AACR 2025  Business Wire

Zai Lab Announces Acceptance of Biologics License Application for TIVDAK for the Treatment of Pat...

Zai Lab Announces Acceptance of Biologics License Application for TIVDAK for the Treatment of Patients with Recurrent or Metastatic Cervical Cancer  Business Wire

Zai Lab Shareholders Approve Key Proposals at AGM - TipRanks

Zai Lab Shareholders Approve Key Proposals at AGM  TipRanks

Zai Lab Limited Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth...

Zai Lab Limited Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b Positive First-Line Gastric Cancer  MarketScreener

Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Ant...

Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients with Extensive-Stage Small Cell Lung Cancer at 2025 ASCO Annual Meeting  Business Wire

Bristol Myers partner Zai Lab plots KarXT filing in China after trial win - Fierce Pharma

Bristol Myers partner Zai Lab plots KarXT filing in China after trial win  Fierce Pharma

How the Zai farming technique is transforming soil fertility in North Cameroon - Mongabay

How the Zai farming technique is transforming soil fertility in North Cameroon  Mongabay

Zai Lab Limited: Banking On Chinese Pharma Growth (NASDAQ:ZLAB) - Seeking Alpha

Zai Lab Limited: Banking On Chinese Pharma Growth (NASDAQ:ZLAB)  Seeking Alpha

Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2...

Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2025  Business Wire

Vertex out-licenses povetacicept to Zai Lab - The Pharma Letter

Vertex out-licenses povetacicept to Zai Lab  The Pharma Letter

Zai Lab Announces Acceptance of Supplemental New Drug Application for Repotrectinib for Patients ...

Zai Lab Announces Acceptance of Supplemental New Drug Application for Repotrectinib for Patients with NTRK-Positive Solid Tumors  Business Wire

As DLL3 heats up, early data for Zai Lab's ADC sets up case for differentiation - FirstWord Pharma

As DLL3 heats up, early data for Zai Lab's ADC sets up case for differentiation  FirstWord Pharma

Zai Lab Announces Acceptance of New Drug Application for KarXT for the Treatment of Schizophrenia...

Zai Lab Announces Acceptance of New Drug Application for KarXT for the Treatment of Schizophrenia  Business Wire

Zai Lab Announces Pricing of Public Offering of American Depositary Shares - Business Wire

Zai Lab Announces Pricing of Public Offering of American Depositary Shares  Business Wire

Zai Lab Announces Participation in Investor Conferences in June 2025 - Yahoo Finance

Zai Lab Announces Participation in Investor Conferences in June 2025  Yahoo Finance

Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (T...

Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting  Business Wire

Institutional investors in Zai Lab Limited (NASDAQ:ZLAB) see US$441m decrease in market cap last ...

Institutional investors in Zai Lab Limited (NASDAQ:ZLAB) see US$441m decrease in market cap last week, although long-term gains have benefitted them.  simplywall.st

Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tu...

Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer  Business Wire

Meet Fu Zai, China's First Police Corgi With 400,000 Followers And A Nose For Trouble - NDTV

Meet Fu Zai, China's First Police Corgi With 400,000 Followers And A Nose For Trouble  NDTV

As other Big Pharmas face local headwinds, Pfizer doubles down on China commitment with Zai Lab a...

As other Big Pharmas face local headwinds, Pfizer doubles down on China commitment with Zai Lab antimicrobial marketing pact  Fierce Pharma

Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310...

Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 at 2025 ASCO Annual Meeting  Business Wire

Zai Lab Announces Strategic Partnership with MediLink Therapeutics to Develop a Novel LRRC15 Anti...

Zai Lab Announces Strategic Partnership with MediLink Therapeutics to Develop a Novel LRRC15 Antibody-Drug Conjugate  Business Wire

Cantor Fitzgerald reiterates overweight rating on Zai Lab stock - Investing.com

Cantor Fitzgerald reiterates overweight rating on Zai Lab stock  Investing.com

Zai Lab Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the Treatme...

Zai Lab Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the Treatment of Small Cell Lung Cancer (SCLC)  Business Wire

Zai steps down steps down from general manager role at Tundra Esports, returns to 'free agency' -...

Zai steps down steps down from general manager role at Tundra Esports, returns to 'free agency'  GosuGamers

Insider Sell: Yajing Chen Sells 9,618 Shares of Zai Lab Ltd (ZLA - GuruFocus

Insider Sell: Yajing Chen Sells 9,618 Shares of Zai Lab Ltd (ZLA  GuruFocus

Meet Zai . | Fine art photographer & Cinematographer - SHOUTOUT LA

Meet Zai . | Fine art photographer & Cinematographer  SHOUTOUT LA

Insider Sell: William Lis Sells 13,814 Shares of Zai Lab Ltd (ZLAB) - GuruFocus

Insider Sell: William Lis Sells 13,814 Shares of Zai Lab Ltd (ZLAB)  GuruFocus

Zai Lab Reports Positive Topline Data from Phase 3 Bridging Trial Evaluating KarXT for the Treatm...

Zai Lab Reports Positive Topline Data from Phase 3 Bridging Trial Evaluating KarXT for the Treatment of Schizophrenia in China  Business Wire

Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth (ZLAB) - Seek...

Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth (ZLAB)  Seeking Alpha

An Interview With YTB Fatt, the Hardest New Rapper Out of West Memphis - Passion of the Weiss

An Interview With YTB Fatt, the Hardest New Rapper Out of West Memphis  Passion of the Weiss

Adnan Zai - Crain's Cleveland Business

Adnan Zai  Crain's Cleveland Business

Zai Lab Ltd SEC 10-Q Report - TradingView

Zai Lab Ltd SEC 10-Q Report  TradingView

Zai Bennett unveils BBCS Productions leadership changes - Televisual

Zai Bennett unveils BBCS Productions leadership changes  Televisual

Zai Lab Q1 2025 Earnings Preview: Key Financial Results Coming May 8 - Stock Titan

Zai Lab Q1 2025 Earnings Preview: Key Financial Results Coming May 8  Stock Titan

Zai Lab announces acceptance of BLA for TIVDAK in cervical cancer - Yahoo Finance

Zai Lab announces acceptance of BLA for TIVDAK in cervical cancer  Yahoo Finance

Biotech Stock In A Base As Sales Grow 66% And Losses Improve - Investor's Business Daily

Biotech Stock In A Base As Sales Grow 66% And Losses Improve  Investor's Business Daily

Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO - Bus...

Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO  Business Wire

Zai Lab earnings beat by $0.42, revenue fell short of estimates - Investing.com

Zai Lab earnings beat by $0.42, revenue fell short of estimates  Investing.com

Zai Lab to Announce Third Quarter 2024 Financial Results and Recent Corporate Updates on November...

Zai Lab to Announce Third Quarter 2024 Financial Results and Recent Corporate Updates on November 12, 2024  BioSpace

Team Liquid highlighted the significant differences between Zai and 33 - Hawk Live

Team Liquid highlighted the significant differences between Zai and 33  Hawk Live

Abu biyar da tarihi ba zai taɓa manta Aminu Dantata da su ba - TRT Global

Abu biyar da tarihi ba zai taɓa manta Aminu Dantata da su ba  TRT Global

Zai Lab partners with Pfizer to commercialise Xacduro in China - World Pharmaceutical Frontiers

Zai Lab partners with Pfizer to commercialise Xacduro in China  World Pharmaceutical Frontiers

Zhu Zhu Zai: Ex-private dining chef sells lu rou fan & braised pork pizza from $3.80 - Yahoo

Zhu Zhu Zai: Ex-private dining chef sells lu rou fan & braised pork pizza from $3.80  Yahoo

Chengdu 2025: Meet the panda SHU BAO and the monkey JIN ZAI - The World Games

Chengdu 2025: Meet the panda SHU BAO and the monkey JIN ZAI  The World Games

Janus Henderson Group's Strategic Acquisition of Zai Lab Shares - GuruFocus

Janus Henderson Group's Strategic Acquisition of Zai Lab Shares  GuruFocus

Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say - Nasdaq

Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say  Nasdaq

Zai Lab’s Growth Strategy And China’s Policy Reforms Set Path For Profitability By 2025 - Seeking...

Zai Lab’s Growth Strategy And China’s Policy Reforms Set Path For Profitability By 2025  Seeking Alpha

Tinubu zai mayar da Fubara kujerarsa, amma ba zai yi takarar 2027 - RFI

Tinubu zai mayar da Fubara kujerarsa, amma ba zai yi takarar 2027  RFI

Who is Palwasha Mohammad Zai Khan? Pakistani Senator’s Ayodhya remarks spark outrage - Times of I...

Who is Palwasha Mohammad Zai Khan? Pakistani Senator’s Ayodhya remarks spark outrage  Times of India

Sky Content Boss Zai Bennett Jumps Ship to BBC Studios Productions as CEO and Chief Creative Offi...

Sky Content Boss Zai Bennett Jumps Ship to BBC Studios Productions as CEO and Chief Creative Officer  Variety

Zai Lab Announces Participation in Investor Conferences in March 2025 - Business Wire

Zai Lab Announces Participation in Investor Conferences in March 2025  Business Wire

Ko cin fara da shinge zai iya maye gurbin naman kaza da na shanu? - BBC

Ko cin fara da shinge zai iya maye gurbin naman kaza da na shanu?  BBC

Tchiroma zai kalubalanci Paul Biya a zaben Kamaru - DW

Tchiroma zai kalubalanci Paul Biya a zaben Kamaru  DW

Zai Nomura Celebrated for Profound Exploration of “Life and Death” with Shiseido Art Egg Award - ...

Zai Nomura Celebrated for Profound Exploration of “Life and Death” with Shiseido Art Egg Award  NiEW

Sky’s Zai Bennett Heading To BBC Studios To Run Production Arm - Deadline

Sky’s Zai Bennett Heading To BBC Studios To Run Production Arm  Deadline

BBC Studios Productions Names Sky’s Zai Bennett CEO and Chief Creative Officer - The Hollywood Re...

BBC Studios Productions Names Sky’s Zai Bennett CEO and Chief Creative Officer  The Hollywood Reporter

The ZAI Method: Reversing Desertification in West Africa - The Borgen Project

The ZAI Method: Reversing Desertification in West Africa  The Borgen Project

Vertex and Zai Lab enter into partnership to treat autoimmune diseases in China, Taiwan, Singapor...

Vertex and Zai Lab enter into partnership to treat autoimmune diseases in China, Taiwan, Singapore  BioSpectrum Asia

TianTong ex-bankruptcy head sets up new firm Zai Sheng - Law.asia

TianTong ex-bankruptcy head sets up new firm Zai Sheng  Law.asia

Zai Lab’s DLL3 ADC Emerges As New Force In ES-SCLC Race - insights.citeline.com

Zai Lab’s DLL3 ADC Emerges As New Force In ES-SCLC Race  insights.citeline.com

After fleeing Taliban and abuse, Afghan woman in Canada for 8 years told she's being deported soo...

After fleeing Taliban and abuse, Afghan woman in Canada for 8 years told she's being deported soon  CBC

MDD ta ce yakin Sudan zai iya shiga Afirka ta Tsakiya - DW

MDD ta ce yakin Sudan zai iya shiga Afirka ta Tsakiya  DW